Elsevier,
Neuropharmacology, Volume 259, 15 November 2024
This review explores using nanotechnology to enhance the delivery of neuroprotective phytochemicals from medicinal plants for Alzheimer's disease (AD), addressing issues of bioavailability, solubility, and blood-brain barrier penetration, and highlights the potential of nanocarriers to revolutionize neuroprotective drug delivery and improve patient outcomes.
Elsevier,
Brain Research, Volume 1843, 15 November 2024
This study developed a novel mouse model with tamoxifen-inducible knockout of the Gnpat gene, enabling late-onset plasmalogen deficiency to investigate its role in Alzheimer's disease. The model exhibited significant plasmalogen reduction and associated behavioral and nerve function changes, providing a valuable tool for future research on plasmalogen involvement in neurodegeneration and potential therapies.
Elsevier,
Language and Communication, Volume 99, November 2024
This research conducted semi-structured interviews to investigate how secondary school students in England make sense of different creative uses of metaphor and metonymy in a sample of slogans shared on social media for the Global Climate Strikes and #FridaysForFuture. The findings suggest that different creative uses prompted different kinds of thinking about climate change and its relevance to students’ personal lives.
Elsevier,
International Journal of Law and Psychiatry, Volume 97, 1 November 2024
The prevalence of borderline personality disorder (BPD) in adults who have in been in prison is higher compared to the general population. Women have higher prevalence rates of BPD in prison compared to men. This article examines the nature of BPD in prisons and to help to inform prison-staff education, funding and intervention options, and adequate care for an already at-risk population.
Elsevier,
Annals of 3D Printed Medicine, Volume 16, November 2024
3D printing enables the creation of customized vaginal drug delivery systems that can improve women's healthcare by providing personalized, targeted, and controlled therapeutic solutions. Despite challenges, this innovative approach holds promise to unlock new possibilities for empowering women through advanced and patient-centric drug delivery technologies.
